Mingzhi Zhang

10PUBLICATIONS
7CO-AUTHORS
Tumour immunologyMedical bacteriologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 20, 2025
Clinical features and prognostic factors of intravascular large B-cell lymphoma: a cohort study of 20 patients from 2018 to 2024.

Yaqing Li, Suxiao Li, Xiyang Liu

|Sep 11, 2024
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies.

Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang

|Nov 05, 2021
CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3.

Mei Mei, Yingjun Wang, Wenting Song

|Aug 18, 2020
Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases.

Lijun Du, Lei Zhang, Ling Li

|May 23, 2020
Primary Causes of Death in Patients with Non-Hodgkin's Lymphoma: A Retrospective Cohort Study.

Mei Mei, Yingjun Wang, Wenting Song

|Mar 12, 2020
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.

Xinran Ma, Ling Li, Lei Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Zhaoming Li

1 joint publications

Weili Xue

1 joint publications

Xuan Lan

1 joint publications

Xinran Ma